|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Medicine, Divisions of Diabetes and Infectious Diseases, Helsinki University Central Hospital, Helsinki, Finland
2 Department of Medicine, Division of Diabetes, Helsinki University Central Hospital, Helsinki, Finland
* To whom correspondence should be addressed. E-mail: jussi.sutinen{at}hus.fi.
Highly active antiretroviral therapy (HAART) is associated with metabolic adverse events such as lipodystrophy in HIV-infected patients. The objective of the present study was to evaluate the effects of HAART-associated lipodystrophy on resting energy expenditure and caloric intake. In this cross-sectional study we compared resting energy expenditure (REE) and energy intake in 30 HAART-treated patients with lipodystrophy (HAART+LD+) with 13 HAART-treated patients without lipodystrophy (HAART+LD-). REE was measured using indirect calorimetry and energy intake by a 3-day diary of food intake. REE (5180 ± 160 vs 4260 ± 150 J/min, P<0.01) and also REE expressed per fat free mass (86 ± 1 vs 78 ± 2 J/kg fat free mass · min, P<0.01) were significantly higher in the HAART+LD+ than the HAART+LD- group. Rate of lipid oxidation was significantly higher in the HAART+LD+ compared to the HAART+LD- group. Total energy and fat intakes were significantly increased in the HAART+LD+ compared to the HAART+LD- group. These results imply that HAART-associated lipodystrophy is associated with increased REE and lipid oxidation, and with increased caloric and fat intake.
This article has been cited by other articles:
![]() |
L. A Kosmiski, D. H Bessesen, S. A Stotz, J. R Koeppe, and T. J Horton Short-term overfeeding increases resting energy expenditure in patients with HIV lipodystrophy Am. J. Clinical Nutrition, October 1, 2007; 86(4): 1009 - 1015. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Koska, E. Ortega, C. Bogardus, J. Krakoff, and J. C. Bunt The effect of insulin on net lipid oxidation predicts worsening of insulin resistance and development of type 2 diabetes mellitus Am J Physiol Endocrinol Metab, July 1, 2007; 293(1): E264 - E269. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |